Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)
- Conditions
- Dementia AlzheimersDepression in Old AgeDementia FrontotemporalAgingParkinson Disease
- Interventions
- Device: Transcranial Magnetic Stimulation
- Registration Number
- NCT05967390
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
Scalp to cortex distance (SCD), as a key technological parameter of brain stimulation, has been highlighted in the guidelines of non-invasive brain stimulation. However, in the context of age-related brain changes, the region-specific SCD and its impact on stimulation-induced electric field in different types of neurodegenerative diseases remain unclear.
- Detailed Description
Objective: This study aimed to investigate the region-specific SCD and its relationship with morphometric features and cognitive function in age- and disease-specific populations. Methods: The SCD and cortical thickness (CT) of left primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) were measured in cognitively normal adults and dementia patients. CT-adjusted SCD was used to control the influence of CT on SCD. Head model was developed to simulate the impact of SCD on the electric field induced by transcranial electrical stimulation.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 488
- Right-handed as assessed by the Edinburgh Inventory
- Able to attend TMS interventions
- Consent
- Independent in daily life activities
- Uncorrected visual or auditive deficits not allowing the realization of the test
- Evolutive disease (such as cancer)
- Neurological or psychiatric antecedent
- Counter-indication to MRI
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Neurocognitive disorder (NCD) Transcranial Magnetic Stimulation The NCD patients are defined with a chronological age over 60 years and a Montreal Cognitive Assessment (MoCA) total score between 22 and 26.
- Primary Outcome Measures
Name Time Method Scalp-to-cortex distance will be measured using geometric brain model Baseline Scalp-to-cortex distance (SCD), as a geometric feature, will measured in the Brainsight TMS neuronavigation system.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Tai Po Hospital
ðŸ‡ðŸ‡°Hong Kong, Hong Kong